Tobacco Use and Dependence: An Updated Review of Treatments

Tobacco use has been cited as the chief avoidable cause of illness and death in our society and accounts for more than 435,000 deaths each year in the United States. Smoking is a known cause of multiple cancers, heart disease, stroke, complications of pregnancy, chronic obstructive pulmonary disease (COPD), and many other diseases. In addition, research has documented the substantial health dangers of involuntary exposure to tobacco smoke. Despite these health dangers and the public's awareness of those dangers, tobacco use remains surprisingly prevalent. Recent estimates are that about 20 percent of adult Americans smoke, representing approximately 45 million current adult smokers. Moreover, tobacco use remains a pediatric disease. Each day, about 4,000 youth ages 12 to 17 years smoke their first cigarette, and about 1,200 children and adolescents become daily cigarette smokers. As a result, new generations of Americans are at risk for the extraordinarily harmful consequences of tobacco use. Tobacco use exacts a heavy cost to society as well as to individuals. Smoking-attributable health care expenditures are estimated at $96 billion per year in direct medical expenses and $97 billion in lost productivity. Despite the tragic consequences of tobacco use, clinicians and health care systems often fail to treat it consistently and effectively despite substantial evidence that even brief interventions can be effective among many different populations of smokers. Also, the use of FDA-approved, evidence-based, effective medication remains very low. This activity, based on the Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update, will help learners understand tobacco dependence as a chronic disease and instruct learners on how to initiate clinical interventions using a brief intervention model.

Target Audience

This activity is intended to meet the needs of all professionals who provide healthcare to tobacco users. This includes physicians, nurses, nurse practitioners, physician assistants, medical assistants, dentists, hygienists, respiratory therapists, psychologists, social workers, substance abuse counselors, mental health counselors, pharmacists, and others.

Learning Objectives

Upon completion of this activity, participants should be able to: 

  1. Describe the rationale for treating tobacco dependence 
  2. Explain why tobacco dependence is a chronic disease 
  3. Initiate clinical interventions for tobacco users who are willing to quit as well as users who are not willing to make a quit attempt 
  4. Assist users attempting to quit with strategies designed to prevent relapse 
  5. Implement appropriate strategies to assist special populations of smokers ​
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 Iowa Board of Nursing Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
Course opens: 
03/15/2017
Course expires: 
03/15/2019
Cost:
$0.00
Parent activity set: 
Rating: 
0

Michael C Fiore, MD, MPH

Faculty/Author
Founder and Director of the Center for Tobacco Research and Intervention (CTRI), Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin

Planning Committee
 

Robert Adsit, MEd

Committee Chair
Outreach Director
University of Wisconsin
School of Medicine
and Public Health
Madison, Wisconsin

Sandra Galles, MS, RN, APNP, GNP-BC

Continuing Education in Nursing Staff
University of Wisconsin -Madison School of Nursing 
Madison, Wisconsin

Julie Lenard, RN

Planning Committee
Content Reviewer

Aspirus Network
Wausau, Wisconsin

Julie Martinelli

OCPD Staff
University of Wisconsin
School of Medicine
and Public Health
Madison, Wisconsin

Faculty Disclosure


It is the policy of the University of Wisconsin–Madison ICEP that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests* in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussions of unlabeled/unapproved uses of drugs or devices during the educational activity. For this educational activity all conflicts of interests have been resolved and detailed disclosures are listed below:


Michael C. Fiore, MD, MPH has no relevant relationships to disclose in regard to this activity.
Robert Adsit, MEd has no relevant relationships to disclose in regard to this activity.
Sandra Galles, MS, RN, APNP, GNP-BC has no relevant relationships to disclose in regard to this activity.
Julie Lenard, RN has no relevant relationships to disclose in regard to this activity.
Julie Martinelli has no relevant relationships to disclose in regard to this activity.

* The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.

Disclosure of Unlabeled Use: The University of Wisconsin–Madison ICEP advises the participant that this continuing medical education activity does NOT contain reference(s) to unlabeled or unapproved uses of drugs or devices

Jointly Accredited Provider Logo

In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


 

American Medical Association

The University of Wisconsin–Madison ICEP designates this enduring material for maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC) & Iowa Board of Nursing

The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.00 ANCC and Iowa contact hours. 

The University of Wisconsin-Madison School of Nursing is Iowa Board of Nursing provider 350. A copy of the evaluation(s) may be sent to the Iowa Board of Nursing, 400 SW 8th St., Suite B, Des Moines, IA 50309.

Continuing Education Units (CEUs)

The University of Wisconsin–Madison, as a member of the University Continuing Education Association (UCEA), authorizes this program for .1 CEUs or 1 hours.

---------------------------------------------------------------

The University of Wisconsin provides equal opportunities in employment and programming, including Title IX requirements. The University of Wisconsin School of Medicine and Public Health fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify the Office of Continuing Professional Development in Medicine and Public Health.

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 Iowa Board of Nursing Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours

Accreditation Period

Course opens: 
03/15/2017
Course expires: 
03/15/2019

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

Free, current version of Internet Explorer, Firefox, Safari, or Chrome. Some older browsers and Microsoft Edge could produce error messages or not display the content correctly. 

Free, current version of Adobe Acrobat Reader or other .pdf reader